20% OFF shipping at oderzo.it on orders over $79 + up to 10% OFF products
oderzo.it
home > EEDi-5285 > EEDi-5285
download picture
EEDi-5285EEDi 5285 is an exceptionally potent and orally active embryonic ectoderm development (EED) inhibitor with an IC50 value of 0. 2 nM for binds to the EED protein. EEDi 5285 has anti cancer activity. Product information CAS Number: 2488952 40 3 Molecular Weight: 479. 53 Formula: C24H22FN5O3S Chemical Name: 8 (6 cyclopropylpyridin 3 yl) N [(5 fluoro 2,3 dihydro 1 benzofuran 4 yl)methyl] 1 methanesulfonylimidazo[1,5 c]pyrimidin 5 amine Smiles:
Shopping security

Shopping security

Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols

EEDi-5285 is an exceptionally potent and orally active embryonic ectoderm development (EED) inhibitor with an IC50 value of 0.2 nM for binds to the EED protein. EEDi-5285 has anti-cancer activity.

Product information

CAS Number: 2488952-40-3

Molecular Weight: 479.53

Formula: C24H22FN5O3S

Chemical Name: 8-(6-cyclopropylpyridin-3-yl)-N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-1-methanesulfonylimidazo[1,5-c]pyrimidin-5-amine

Smiles: CS(=O)(=O)C1N=CN2C=1C(=CN=C2NCC1=C(F)C=CC2OCCC1=2)C1=CN=C(C=C1)C1CC1

InChiKey: BMLWIABJRSYZDK-UHFFFAOYSA-N

InChi: InChI=1S/C24H22FN5O3S/c1-34(31,32)23-22-17(15-4-6-20(26-10-15)14-2-3-14)11-27-24(30(22)13-29-23)28-12-18-16-8-9-33-21(16)7-5-19(18)25/h4-7,10-11,13-14H,2-3,8-9,12H2,1H3,(H,27,28)

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

How to use

In Vitro:

EEDi-5285 inhibits cell growth with IC50 values of 20 pM and 0.5 nM in the Pfeiffer and KARPAS422 lymphoma cell lines, respectively, carrying an EZH2 mutation.

In Vivo:

EEDi-5285 (compound 28; 50-100 mg/kg; oral gavage; daily; for 28 days; SCID mice) treatment achieves complete and durable tumor regression in the KARPAS422 xenograft model in mice with oral administration. A single 100 mg/kg oral administration of EEDi-5285 (compound 28) effectively reduces the level of H3K27me3 at 24 h in KARPAS422 tumor tissue in mice. EEDi-5285 (compound 28) achieves a Cmax of 1.8 μM and an AUC of 6.0 h▪μg/ml with 10 mg/kg oral administration and has an oral bioavailability (F) of 75%. EEDi-5285 has a moderate volume of distribution of 1.4 L/kg and a terminal T1/2 of approximately 2 h.

Products are for research use only. Not for human use.

EEDi-5285

Item no : 41695815800
sold recently : Login >>
US$ 120.00
Pay in 4 interest-free payments of $30.00 Learn more
Min. order: 1piece

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Oct 27 - Nov 1

Enjoy 20% off shipping

US$ 120.00

1-11

US$ 108.00

12-35

US$ 84.00

36-59

US$ 72.00

60+

US$40

Get now

Sign up to your membership to get coupons up to

15%

Get now

Opportunity to enjoy order discount up to 15% off

Please add the products
Shipping Notes
  • Free Standard Shipping on $100+ Orders to the USA.
  • Except Preorder products are shipped in 48 hours.
  • Delivery to the USA:
  1. Standard Shipping : 3-10 business days
  • If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

Discover Niche Categories That Outsell

Top-Converting Item to Boost Your Average Order

recommand products

Related Searches